United Therapeutics Corporation
US ˙ NasdaqGS ˙ US91307C1027

SecurityUTHR / United Therapeutics Corporation
InstitutionClean Yield Group
Latest Disclosed Ownership300 shares
Latest Disclosed Value $ 177,894
Clean Yield Group ownership in UTHR / United Therapeutics Corporation

On April 14, 2026 - Clean Yield Group filed a 13F-HR form disclosing ownership of 300 shares of United Therapeutics Corporation (US:UTHR) valued at $177,894 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 300 shares of United Therapeutics Corporation. This represents a change in shares of 0.00% during the quarter. The current value of the position is $164,841 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-14 2026-03-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 178 21.23 0.0501
2026-01-26 2025-12-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 146 16.80 0.0406
2025-10-23 2025-09-30 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 126 45.35 0.0355
2025-07-17 2025-06-30 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 86 -6.52 0.0258
2025-04-14 2025-03-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 92 -12.38 0.0301
2025-01-13 2024-12-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 106 -1.87 0.0337
2024-10-07 2024-09-30 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 108 12.63 0.0341
2024-07-10 2024-06-30 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 96 39.71 0.0357
2024-05-29 2024-03-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 69 4.62 0.0268
2024-01-24 2023-12-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 66 -7.14 0.0278
2023-10-12 2023-09-30 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 70 6.06 0.0312
2023-07-26 2023-06-30 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 66 -1.49 0.0273
2023-04-26 2023-03-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 67 -19.28 0.0286
2023-01-31 2022-12-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 83 31.75 0.0358
2022-10-31 2022-09-30 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 63 -11.27 0.0292
2022-07-18 2022-06-30 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 71 31.48 0.0293
2022-04-25 2022-03-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 54 -16.92 0.0191
2022-01-24 2021-12-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 0 0.00 65 18.18 0.0208
2021-10-27 2021-09-30 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 300 150 100.00 55 103.70 0.0180
2021-07-26 2021-06-30 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 150 150 27 0.0092
2021-04-26 2021-03-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 0 -75 -100.00 0 -100.00
2021-01-26 2020-12-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 75 75 11 0.0040
2016-01-27 2015-12-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 0 0 0 0.0000
2015-10-29 2015-09-30 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 0 -2,225 -100.00 0 -100.00
2015-07-31 2015-06-30 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 2,225 -1,570 -41.37 387 -40.83 0.1778
2015-04-24 2015-03-31 13F UNITED THERAPEUTICS CORP DEL COM Stock 91307C102 3,795 3,795 70.56 654 68.99 0.2804
2015-01-29 2014-12-31 13F United Therapeutics COM 91307C102 0 -14,826 -100.00 0 -100.00
2014-10-27 2014-09-30 13F United Therapeutics COM 91307C102 14,826 -469 -3.07 1,907 40.95 0.9159
2014-07-21 2014-06-30 13F United Therapeutics COM 91307C102 15,295 1,815 13.46 1,353 6.70 0.6684
2014-04-24 2014-03-31 13F United Therapeutics COM 91307C102 13,480 13,480 1,268 0.6557
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.